Stephan Lobitz

Koblenz, RP, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.

Journal: The New England journal of medicine

Published: June 11, 2026

Progressive short stature in Pearson syndrome and the impact of organ failure.

Progressive short stature in Pearson syndrome and the impact of organ failure.

Journal: Molecular genetics and metabolism

Published: February 03, 2026

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland.

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland.

Journal: Mycoses

Published: April 01, 2025

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.

Journal: HemaSphere

Published: July 25, 2024

Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel.

Gene therapy in transfusion-dependent non-β0/β0 genotype β-thalassemia: first real-world experience of beti-cel.

Journal: Blood advances

Published: June 28, 2024

Exagamglogene Autotemcel for Severe Sickle Cell Disease.

Exagamglogene Autotemcel for Severe Sickle Cell Disease.

Journal: The New England journal of medicine

Published: April 25, 2024

The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.

The German sickle cell disease registry reveals a surprising risk of acute splenic sequestration and an increased transfusion requirement in patients with compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression.

Journal: European journal of haematology

Published: March 13, 2024

Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.

Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective.

Journal: The Lancet. Haematology

Published: May 31, 2023

Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency.

Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency.

Journal: Gastroenterology

Published: September 08, 2022

Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.

Simultaneous newborn screening for sickle cell disease, biotinidase deficiency, and hereditary tyrosinemia type 1 with an optimized tandem mass spectrometry protocol.

Journal: Annals of hematology

Published: November 04, 2021

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome.

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011-2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome.

Journal: Journal of clinical medicine

Published: August 31, 2021

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea.

Journal: Haematologica

Published: April 11, 2021

Showing 1-12 of 30

Last Updated: 09/26/2026